🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vignesh T. Packiam

Rutgers, The State University of New Jersey

ORCID: 0000-0001-8397-7797

Also affiliated with University of Iowa, Saint Barnabas Medical Center, Robert Wood Johnson University Hospital, Johnson University, University of Iowa Hospitals and Clinics, Rutgers Sexual and Reproductive Health and Rights, Southwestern Medical Center, Rutgers Cancer Institute, The University of Texas Southwestern Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.842Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer

British Journal of Urology(2024)10.1111/bju.16509
Top 24%
0.842DataRank
Top 24%27 citations

Ashish M. Kamat, Michael A. O’Donnell, Drupad Annapureddy, Jeffrey Howard, Wei Shen Tan +19 more

Papers

Driven by 7 papers — median percentile 76. Top paper: “Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer”.

Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer

British Journal of Urology(2024)10.1111/bju.16509
Top 24%
0.842DataRank
Top 24%27 citations

Ashish M. Kamat, Michael A. O’Donnell, Drupad Annapureddy, Jeffrey Howard, Wei Shen Tan +19 more

Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non–muscle-invasive Bladder Cancer (BRIDGE)

European Urology Focus(2023)10.1016/j.euf.2023.06.006
N/A
0DataRank · unranked
49 citations

Xiangying Chu, Noah M. Hahn, Eugene J. Pietzak, Angela B. Smith, Daniel H. Shevrin +9 more

Simultaneous versus staged partial nephrectomies for bilateral synchronous solid renal masses

Urologic Oncology Seminars and Original Investigations(2020)10.1016/j.urolonc.2020.04.002
N/A
0DataRank · unranked
13 citations

Matvey Tsivian, Christine M. Lohse, John C. Cheville, Stephen A. Boorjian, R. Houston Thompson +2 more

Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder Cancer

European Urology Oncology(2025)10.1016/j.euo.2025.04.006
N/A
0DataRank · unranked
6 citations

Ian M. McElree, Saum Ghodoussipour, Vivek Nimgaonkar, Viswesh Krishna, Joon Kyung Kim +15 more

Drug‐releasing intravesical floating technology for sequential gemcitabine and docetaxel in non‐muscle‐invasive bladder cancer

British Journal of Urology(2025)10.1111/bju.70060
N/A
0DataRank · unranked
3 citations

Kaitlyn A. McClintic, Emily Witt, Ikenna Nwosu, Kyle R. Balk, César P. Reis +7 more

Extended Outcomes of Intravesical Valrubicin and Docetaxel as a Secondary Salvage Treatment for Recalcitrant High-risk Non–muscle-invasive Bladder Cancer

European Urology Focus(2025)10.1016/j.euf.2025.05.022
N/A
0DataRank · unranked
1 citations

Ryan L. Steinberg, Helen Y. Hougen, Sarah L. Mott, Vignesh T. Packiam, Michael A. O’Donnell +1 more

Contemporary Treatment of NMIBC—Is It Time to Move on from BCG?

Journal of Clinical Medicine(2024)10.3390/jcm13144112
N/A
0DataRank · unranked
9 citations

Vignesh T. Packiam, Rachel Passarelli